Dr. Majid Safa, Vice President of Research and Technology at Iran University of Medical Sciences, emphasized the necessity for targeted investments and the development of technological products in regenerative medicine during the opening ceremony of the Fifth Congress on Advances in Tissue Engineering and Regenerative Medicine. He highlighted the interdisciplinary nature of regenerative medicine, which encompasses areas from polymer engineering to clinical sciences, leading to innovative treatment methods.

Dr. Safa noted the importance of aligning doctoral education with practical outcomes, stressing that research should contribute to patient care. He praised recent achievements by young researchers, including a media-highlighted wound healing product developed by a student.

He urged for precise and calculated expenditures in the current economic climate, particularly regarding the establishment of laboratories and clean rooms, advocating against creating underutilized facilities. Dr. Safa also called for greater involvement from the private sector in technology development, indicating that marketable products could attract investment.

Addressing the need for regulation, he pointed out the existence of unauthorized medical practices and stressed the importance of organizing these activities to enhance transparency and uphold medical standards. In conclusion, he expressed gratitude to the congress organizers and hoped that the event would yield significant advancements for the health system and elevate the practical and scientific capabilities of researchers in the field.